Brief: Armistice Capital Llc Reports A Stake Of 7.7% In Aytu Bioscience As Of Dec. 11 - SEC Filing
Dec 21 (Reuters) - Aytu BioScience Inc AYTU.O :
* ARMISTICE CAPITAL, LLC REPORTS A STAKE OF 7.7% IN AYTU
BIOSCIENCE AS OF DEC. 11 - SEC FILING
* ARMISTICE CAPITAL SAYS PURCHASED SHARES OF AYTU BASED ON
BELIEF
THAT SHARES, WHEN PURCHASED, WERE UNDERVALUED
Source: [https://bit.ly/2JaBDAh]
Further company coverage: AYTU.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations